Imperial College London Featured PhD Programmes
Xi’an Jiaotong-Liverpool University Featured PhD Programmes
University of Reading Featured PhD Programmes

Transforming data to understanding and knowledge for the sequencing of therapeutic oligonucleotides by mass spectrometry

  • Full or part time
  • Application Deadline
    Wednesday, July 01, 2020
  • Competition Funded PhD Project (European/UK Students Only)
    Competition Funded PhD Project (European/UK Students Only)

Project Description

Supervisor: Prof. G J Langley, Dr E Stulz, Dr A Ray (AstraZeneca), Dr S Holman (AstraZeneca)

Project description

Oligonucleotides are a promising and growing class of therapeutics. There are currently ~10 oligonucleotide drugs on the market, and many more presently in clinical trials. Many of these therapeutic oligonucleotides feature modifications which are designed to protect against degradation or enhance their activity. Conjugation of oligonucleotides has also been used to modulate protein binding and tissue distribution. This analytical PhD project, a collaboration between a world-class mass spectrometry research group and a world-leading pharmaceutical company, will seek to understand the characterisation of these revolutionary drugs.

Mass spectrometry is a key analytical technique used to characterise and structurally elucidate molecules in drug discovery and development using tandem mass spectrometry (MS/MS). This process is underpinned by an understanding of the gas-phase chemistry of the molecules under investigation to interpret the fragment ions formed and relate them back to the original structure.

At present, a deep understanding of the gas-phase ion fragmentation behaviour of therapeutic oligonucleotides is lacking, hampering efforts to characterise them and slowing their journey to market. To address these deficiencies in understanding, this PhD project will seek to investigate the impact of pharmaceutically-relevant modifications on the MS/MS behaviour and gas-phase stability of the oligonucleotides. This will allow mechanisms for the different fragmentation processes to be probed and developed. Using the increased understanding of the ion dissociation pathways, databases of structures and fragmentation trees will be built, hierarchical structural drivers of fragmentation proposed, and protocols for the interpretation of modified oligonucleotides developed. The student will gain experience in a number of fragmentation techniques (CID, HCD, ETD) and different mass analysers, including QToF, FT-ICR and Orbitrap technologies.

This EPSRC CASE Conversion project will be in collaboration with AstraZeneca, and the successful student will have opportunity to undertake a three-month placement at the company’s Macclesfield Research & Development site during the PhD, providing valuable industrial experience. As part of this placement, the student will have access to additional instrumentation not available at Southampton, and will assess the transferability of their findings with the mass spectrometry teams at AstraZeneca in both Macclesfield and Gothenburg. Further, ad hoc visits as required by the progress of the research will be undertaken. The student will also attend AstraZeneca’s PhD Day to present their work, as well as be expected to present posters and orals at international conferences.

This project is well-suited to those with strong skills and a keen interest in analytical chemistry, and its application to the pharmaceutical industry. An interest in physical-organic chemistry is desirable.

Entry Requirements
A very good undergraduate degree (at least a UK 2:1 honours degree, or its international equivalent).

Closing date: 01 July 2020

Funding: full tuition fees for EU/UK students plus for UK students, an enhanced stipend of £15,285 tax-free per annum for up to 3.5 years.

How To Apply

Applications should be made online, please select the academic session 2020-21 “PhD Chemistry (Full time)” as the programme. Please enter John Langley under the proposed supervisor.

Applications should include:
Curriculum Vitae
Two reference letters
Degree Transcripts to date
Apply online:

For further information please contact:

How good is research at University of Southampton in Chemistry?

FTE Category A staff submitted: 44.80

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here

The information you submit to University of Southampton will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.

* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully

FindAPhD. Copyright 2005-2020
All rights reserved.